Tandem Diabetes Care Debt to Equity Ratio 2012-2024 | TNDM

Current and historical debt to equity ratio values for Tandem Diabetes Care (TNDM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Tandem Diabetes Care debt/equity for the three months ending September 30, 2024 was 1.29.
Tandem Diabetes Care Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.72B $0.24B 3.03
2024-06-30 $0.70B $0.23B 3.01
2024-03-31 $0.70B $0.24B 2.87
2023-12-31 $0.64B $0.31B 2.04
2023-09-30 $0.63B $0.31B 1.99
2023-06-30 $0.62B $0.33B 1.88
2023-03-31 $0.62B $0.34B 1.82
2022-12-31 $0.61B $0.44B 1.39
2022-09-30 $0.63B $0.42B 1.48
2022-06-30 $0.59B $0.45B 1.31
2022-03-31 $0.58B $0.44B 1.32
2021-12-31 $0.47B $0.43B 1.09
2021-09-30 $0.46B $0.39B 1.18
2021-06-30 $0.45B $0.35B 1.30
2021-03-31 $0.44B $0.31B 1.41
2020-12-31 $0.35B $0.37B 0.96
2020-09-30 $0.35B $0.33B 1.06
2020-06-30 $0.35B $0.27B 1.30
2020-03-31 $0.14B $0.21B 0.66
2019-12-31 $0.13B $0.20B 0.67
2019-09-30 $0.13B $0.17B 0.75
2019-06-30 $0.11B $0.15B 0.76
2019-03-31 $0.09B $0.12B 0.78
2018-12-31 $0.08B $0.13B 0.57
2018-09-30 $0.07B $0.12B 0.57
2018-06-30 $0.13B $0.03B 5.08
2018-03-31 $0.13B $0.01B 11.21
2017-12-31 $0.12B $-0.03B -4.27
2017-09-30 $0.12B $-0.03B -4.15
2017-06-30 $0.12B $-0.02B -6.39
2017-03-31 $0.12B $-0.00B -61.34
2016-12-31 $0.12B $-0.01B -19.96
2016-09-30 $0.09B $0.01B 16.38
2016-06-30 $0.08B $0.03B 2.40
2016-03-31 $0.08B $0.05B 1.63
2015-12-31 $0.06B $0.06B 0.97
2015-09-30 $0.06B $0.07B 0.80
2015-06-30 $0.05B $0.09B 0.61
2015-03-31 $0.05B $0.10B 0.52
2014-12-31 $0.05B $0.06B 0.95
2014-09-30 $0.05B $0.07B 0.73
2014-06-30 $0.05B $0.08B 0.56
2014-03-31 $0.05B $0.10B 0.46
2013-12-31 $0.05B $0.12B 0.40
2013-09-30 $0.05B $-0.00B -18.28
2013-06-30 $0.05B $0.01B 5.47
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2011-12-31 $0.02B $-0.00B -5.15
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.309B $0.748B
Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.066B 26.11
Intuitive Surgical (ISRG) United States $211.086B 110.36
Alcon (ALC) Switzerland $41.615B 27.84
Edwards Lifesciences (EW) United States $41.156B 26.14
IQVIA Holdings (IQV) United States $35.821B 19.74
IDEXX Laboratories (IDXX) United States $34.331B 40.43
DexCom (DXCM) United States $32.958B 49.63
Waters (WAT) United States $23.988B 35.47
STERIS (STE) Ireland $20.691B 23.82
SONOVA HOLDING (SONVY) Switzerland $19.710B 0.00
Hologic (HOLX) United States $15.740B 17.09
Fresenius Medical Care AG KGaA (FMS) Germany $13.538B 13.90
Globus Medical (GMED) United States $12.364B 31.31
Sysmex ADR (SSMXY) Japan $11.726B 0.00
Penumbra (PEN) United States $10.120B 99.13
Masimo (MASI) United States $9.225B 44.63
Glaukos (GKOS) United States $8.623B 0.00
Teleflex (TFX) United States $8.419B 13.43
Integer Holdings (ITGR) United States $4.729B 26.81
Inari Medical (NARI) United States $4.657B 0.00
PROCEPT BioRobotics (PRCT) United States $3.967B 0.00
Veracyte (VCYT) United States $3.145B 94.37
Nihon Kohden (NHNKY) Japan $2.658B 20.19
LivaNova (LIVN) United Kingdom $2.623B 15.14
Elekta AB (EKTAY) Sweden $2.167B 19.48
TransMedics (TMDX) United States $1.920B 60.85
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
Alphatec Holdings (ATEC) United States $1.641B 0.00
Artivion (AORT) United States $1.288B 85.33
RxSight (RXST) United States $1.225B 0.00
Pulse Biosciences (PLSE) United States $1.083B 0.00
OPKO Health (OPK) United States $1.003B 0.00
Paragon 28 (FNA) United States $0.911B 0.00
AxoGen (AXGN) United States $0.796B 0.00
Mesa Laboratories (MLAB) United States $0.758B 17.88
IRadimed (IRMD) United States $0.750B 40.53
AVANOS MEDICAL, INC (AVNS) United States $0.732B 12.44
SiBone (SIBN) United States $0.700B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.693B 0.00
OrthoPediatrics (KIDS) United States $0.658B 0.00
Semler Scientific (SMLR) United States $0.599B 31.55
Treace Medical Concepts (TMCI) United States $0.543B 0.00
AngioDynamics (ANGO) United States $0.503B 0.00
Delcath Systems (DCTH) United States $0.458B 0.00
Pacific Biosciences Of California (PACB) United States $0.449B 0.00
CVRx (CVRX) United States $0.428B 0.00
Tactile Systems Technology (TCMD) United States $0.418B 22.60
ClearPoint Neuro (CLPT) United States $0.415B 0.00
NeuroPace (NPCE) United States $0.357B 0.00
Alpha Tau Medical (DRTS) Israel $0.273B 0.00
Inogen (INGN) United States $0.249B 0.00
Accuray (ARAY) United States $0.225B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.171B 0.00
Sight Sciences (SGHT) United States $0.144B 0.00
Sensus Healthcare (SRTS) United States $0.108B 11.51
Atossa Genetics (ATOS) United States $0.104B 0.00
908 Devices (MASS) United States $0.104B 0.00
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Vicarious Surgical (RBOT) United States $0.094B 0.00
Monogram Orthopaedics (MGRM) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
Neuronetics (STIM) United States $0.075B 0.00
WORK Medical Technology Group (WOK) China $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
InspireMD (NSPR) Israel $0.071B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.93
Baird Medical Investment Holdings (BDMD) $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Microbot Medical (MBOT) United States $0.033B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.027B 0.00
NexGel (NXGL) United States $0.024B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Aspira Women's Health (AWH) United States $0.008B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00